Editorial: should the inappropriate use of proton pump inhibitors be a quality assurance issue in cirrhotic patients?

Aliment Pharmacol Ther. 2017 Feb;45(3):476-477. doi: 10.1111/apt.13875.
No abstract available

Publication types

  • Editorial
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Humans
  • Liver Cirrhosis*
  • Proton Pump Inhibitors*
  • Risk Factors

Substances

  • Proton Pump Inhibitors